Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 12 month CR rate of ImmunityBio's N-803 in NMIBC trial

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Mar 20, 2022 12:28pm

259 Views

Post# 34529530

RE:RE:RE:RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial

Also thinking is if this Newsletter is really good and brings very positive data and new information on other fronts then will we see conversation in that Newsletter on a move from the TSX Venture to the TSX Senior board along with a possible Nasdaq listing? Something to chew on!

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?